Skip to main content

Advertisement

Table 3 Prevalence of IL10R −1087 genotypes in HCV patients and healthy controls

From: IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort

IL10R −1087 Genotype HCV1 (n = 672) Controls (n = 92) OR
GG 214 (31.8) 48 (52.2%) 0.428 (0.276 - 0.665)
p < 0.001
GA 333 (49.6%) 32 (34.8%) 1.842 (1.169 – 2.903)
p = 0.008
G allele 547 (81.4%) 80 (87.0%) 0.656 (0.347-1.241)
p = 0.192
AA 125 (18.6%) 12 (13.0%) 1.523 (0.806 – 2.881)
p = 0.192
A allele (non-GG) 458 (68.15%) 44 (47.8%) 2.335 (1.504 – 3.625)
    p < 0.001